Published in Biochemistry on February 23, 2010
Alpha-synuclein populates both elongated and broken helix states on small unilamellar vesicles. J Biol Chem (2011) 1.31
Native chemical ligation of thioamide-containing peptides: development and application to the synthesis of labeled α-synuclein for misfolding studies. J Am Chem Soc (2012) 1.04
Binding Interactions of Agents That Alter α-Synuclein Aggregation. RSC Adv (2015) 0.79
Insight into α-synuclein plasticity and misfolding from differential micelle binding. J Phys Chem B (2013) 0.78
A simple method for displaying the hydropathic character of a protein. J Mol Biol (1982) 150.65
Empirical predictions of protein conformation. Annu Rev Biochem (1978) 25.48
Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem (2006) 22.87
The Jalview Java alignment editor. Bioinformatics (2004) 21.74
Why are "natively unfolded" proteins unstructured under physiologic conditions? Proteins (2000) 7.61
Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins. Nat Biotechnol (2004) 7.02
Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron (2000) 6.92
Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes. J Biol Chem (1998) 5.81
DNAWorks: an automated method for designing oligonucleotides for PCR-based gene synthesis. Nucleic Acids Res (2002) 5.75
Alpha-synuclein and neurodegenerative diseases. Nat Rev Neurosci (2001) 5.32
Rationalization of the effects of mutations on peptide and protein aggregation rates. Nature (2003) 4.98
Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1. Anal Biochem (1989) 4.43
Conformational properties of alpha-synuclein in its free and lipid-associated states. J Mol Biol (2001) 4.27
A hydrophobic stretch of 12 amino acid residues in the middle of alpha-synuclein is essential for filament assembly. J Biol Chem (2000) 3.97
Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc Natl Acad Sci U S A (1993) 3.73
Evidence for a partially folded intermediate in alpha-synuclein fibril formation. J Biol Chem (2001) 3.60
Molecular structure of amyloid fibrils: insights from solid-state NMR. Q Rev Biophys (2006) 3.54
Release of long-range tertiary interactions potentiates aggregation of natively unstructured alpha-synuclein. Proc Natl Acad Sci U S A (2005) 3.48
Molecular-level secondary structure, polymorphism, and dynamics of full-length alpha-synuclein fibrils studied by solid-state NMR. Proc Natl Acad Sci U S A (2005) 3.37
alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease. J Biol Chem (1999) 2.91
The 3D profile method for identifying fibril-forming segments of proteins. Proc Natl Acad Sci U S A (2006) 2.88
The fold of alpha-synuclein fibrils. Proc Natl Acad Sci U S A (2008) 2.82
Mechanisms of Parkinson's disease linked to pathological alpha-synuclein: new targets for drug discovery. Neuron (2006) 2.66
Common mechanisms of amyloid oligomer pathogenesis in degenerative disease. Neurobiol Aging (2006) 2.50
Are amyloid diseases caused by protein aggregates that mimic bacterial pore-forming toxins? Q Rev Biophys (2006) 2.47
Computation and analysis of protein circular dichroism spectra. Methods Enzymol (2004) 2.37
Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation. J Biol Chem (1998) 2.32
Investigation of alpha-synuclein fibril structure by site-directed spin labeling. J Biol Chem (2007) 2.30
Dependence of alpha-synuclein aggregate morphology on solution conditions. J Mol Biol (2002) 2.26
Primary sequence independence for prion formation. Proc Natl Acad Sci U S A (2005) 2.21
Role of alpha-synuclein carboxy-terminus on fibril formation in vitro. Biochemistry (2003) 2.18
Lewy bodies. Proc Natl Acad Sci U S A (2006) 2.15
Biophysical properties of the synucleins and their propensities to fibrillate: inhibition of alpha-synuclein assembly by beta- and gamma-synucleins. J Biol Chem (2002) 2.07
Mechanism of thioflavin T binding to amyloid fibrils. J Struct Biol (2005) 2.04
The Zyggregator method for predicting protein aggregation propensities. Chem Soc Rev (2008) 1.81
Defining long-range order and local disorder in native alpha-synuclein using residual dipolar couplings. J Am Chem Soc (2005) 1.75
The core Alzheimer's peptide NAC forms amyloid fibrils which seed and are seeded by beta-amyloid: is NAC a common trigger or target in neurodegenerative disease? Chem Biol (1995) 1.71
Small molecule inhibitors of alpha-synuclein filament assembly. Biochemistry (2006) 1.69
Kinetic control of dimer structure formation in amyloid fibrillogenesis. Proc Natl Acad Sci U S A (2004) 1.52
The N-terminal repeat domain of alpha-synuclein inhibits beta-sheet and amyloid fibril formation. Biochemistry (2003) 1.39
Beta-synuclein inhibits formation of alpha-synuclein protofibrils: a possible therapeutic strategy against Parkinson's disease. Biochemistry (2003) 1.36
A simple algorithm locates beta-strands in the amyloid fibril core of alpha-synuclein, Abeta, and tau using the amino acid sequence alone. Protein Sci (2007) 1.22
Forcing nonamyloidogenic beta-synuclein to fibrillate. Biochemistry (2005) 1.19
Solid-state NMR reveals structural differences between fibrils of wild-type and disease-related A53T mutant alpha-synuclein. J Mol Biol (2008) 1.16
BETASCAN: probable beta-amyloids identified by pairwise probabilistic analysis. PLoS Comput Biol (2009) 1.14
Sequence Determinants for Amyloid Fibrillogenesis of Human alpha-Synuclein. J Mol Biol (2007) 1.09
Role of different regions of alpha-synuclein in the assembly of fibrils. Biochemistry (2007) 1.03
Impact of Tyr to Ala mutations on alpha-synuclein fibrillation and structural properties. Biochim Biophys Acta (2008) 1.02
Characterization of alpha-synuclein interactions with selected aggregation-inhibiting small molecules. Biochemistry (2008) 0.98
Alternate aggregation pathways of the Alzheimer beta-amyloid peptide. An in vitro model of preamyloid. J Biol Chem (2000) 0.95
Effect of pseudorepeat rearrangement on alpha-synuclein misfolding, vesicle binding, and micelle binding. J Mol Biol (2009) 0.95
Characterization of hydrophobic residue requirements for alpha-synuclein fibrillization. Biochemistry (2009) 0.92
The structure and protein binding of amyloid-specific dye reagents. Acta Biochim Pol (2003) 0.91
Phthalocyanine tetrasulfonates affect the amyloid formation and cytotoxicity of alpha-synuclein. Biochemistry (2004) 0.91
Self-propagating beta-sheet polypeptide structures as prebiotic informational molecular entities: the amyloid world. Orig Life Evol Biosph (2009) 0.89
Isomers of human alpha-synuclein stabilized by disulfide bonds exhibit distinct structural and aggregative properties. Biochemistry (2007) 0.84
Structural determinants of integrin recognition by talin. Mol Cell (2003) 4.20
The structure of the integrin alphaIIbbeta3 transmembrane complex explains integrin transmembrane signalling. EMBO J (2009) 2.45
Structure of the integrin beta3 transmembrane segment in phospholipid bicelles and detergent micelles. Biochemistry (2008) 1.80
Structure of the integrin alphaIIb transmembrane segment. J Biol Chem (2008) 1.57
Interactions of platelet integrin alphaIIb and beta3 transmembrane domains in mammalian cell membranes and their role in integrin activation. Blood (2009) 1.41
Alpha-synuclein populates both elongated and broken helix states on small unilamellar vesicles. J Biol Chem (2011) 1.31
Basic amino-acid side chains regulate transmembrane integrin signalling. Nature (2011) 1.30
Recognition of enhancer element-specific histone methylation by TIP60 in transcriptional activation. Nat Struct Mol Biol (2011) 1.29
A combinatorial NMR and EPR approach for evaluating the structural ensemble of partially folded proteins. J Am Chem Soc (2010) 1.11
Dissecting amelogenin protein nanospheres: characterization of metastable oligomers. J Biol Chem (2011) 1.03
Characterization of alpha-synuclein interactions with selected aggregation-inhibiting small molecules. Biochemistry (2008) 0.98
A potentially common peptide target in secreted heat shock protein-90α for hypoxia-inducible factor-1α-positive tumors. Mol Biol Cell (2011) 0.97
Effect of pseudorepeat rearrangement on alpha-synuclein misfolding, vesicle binding, and micelle binding. J Mol Biol (2009) 0.95
Insight into disulfide bond catalysis in Chlamydia from the structure and function of DsbH, a novel oxidoreductase. J Biol Chem (2007) 0.94
Quantitative J correlation methods for the accurate measurement of 13C'-13Calpha dipolar couplings in proteins. J Biomol NMR (2004) 0.89
An environment-dependent structural switch underlies the regulation of carnitine palmitoyltransferase 1A. J Biol Chem (2011) 0.83
Construction of covalent membrane protein complexes and high-throughput selection of membrane mimics. J Am Chem Soc (2012) 0.83
Structural adaptation of tooth enamel protein amelogenin in the presence of SDS micelles. Biopolymers (2014) 0.83
Insight into α-synuclein plasticity and misfolding from differential micelle binding. J Phys Chem B (2013) 0.78
Structural characterization of the regulatory domain of brain carnitine palmitoyltransferase 1. Biopolymers (2014) 0.76
NMR assignment of the periplasmic oxidoreductase DsbH from Chlamydia. Biomol NMR Assign (2007) 0.75